PIPETTE GAZETTE: George Parra (Libich Lab) Receives the Greehey Graduate Fellowship in Children’s Health

September 3, 2020

George Parra, a second-year student in the Biochemical Mechanisms of Medicine discipline in the Integrated Biomedical Sciences program, has received the Greehey Graduate Fellowship in Children’s Health. The Greehey Graduate Fellowship Award in Children’s Health was established by the Greehey family to support students who wish to pursue graduate scientific studies in children’s health sciences especially children’s […]

Luiz O.F. Penalva PhD Awarded CPRIT Grant to Study New Glioblastoma (GBM) Regulator

August 20, 2020

PROJECT SUMMARY Glioblastoma (GBM) is the most common and most aggressive brain tumor type among adults with a 14 months average patient survival. Despite all genomic efforts in recent years, novel therapies based on GBM common mutations and alterations have been disappointing. To build an alternative route, we have been focusing on oncogenic RNA binding […]

Alexander Pertsemlidis, PhD Co-Awarded National Science Foundation Grant.

August 20, 2020

PI: Leonidas Bleris, PhD                       Co-PI: Alexander Pertsemlidis, PhD (UT Dallas)                                              (UT Health San Antonio) PROJECT SUMMARY Collaborative Research: Unraveling extracellular microRNA communication Overview: […]

Physician’s Weekly: PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.

August 20, 2020

Although cancer is the leading cause of disease-related mortality in children, the relative rarity of pediatric cancers poses a significant challenge for developing novel therapeutics to further improve prognosis. Patient-derived xenograft (PDX) models, which are usually developed from high-risk tumors, are a useful platform to study molecular driver events, identify biomarkers and prioritize therapeutic agents.

Luiz O.F. Penalva PhD Awarded CPRIT Grant to Study Glioblastoma (GBM)

August 20, 2020

PROJECT SUMMARY Glioblastoma (GBM) is the most common and most aggressive brain tumor type among adults with a 14 months average patient survival. Despite all genomic efforts in recent years, novel therapies based on GBM common mutations and alterations have been disappointing. To build an alternative route, we have been focusing on oncogenic RNA binding [...]

PIPETTE GAZETTE: CSA Shoutout to Graduating Student Pooja Yadav (Rao Lab)

August 11, 2020

Congratulations to one of our CSA graduate students Pooja Yadav, M.S. (Cancer Biology discipline) who successfully defended her PhD dissertation on June 25!

Health 24: How the coronavirus infects: It can make itself unrecognisable to cells in the body

August 5, 2020

Like a thief in the night, Covid-19 can disguise itself to easily enter and infect cells in the human body. A new research study details what cells are more susceptible to the coronavirus. SARS-CoV-2 can mimic the proteins of a human cell to evade detection by the immune system. Once inside the cell, it can […]

Gupta Lab: COVID19 Press Clippings Archive

July 30, 2020

UNITED PRESS INTERNATIONAL – Researchers identify enzyme that helps COVID-19 evade immune system (Gupta Lab)

July 30, 2020

Researchers announced Friday that they have discovered an enzyme that helps COVID-19 enter cells in the human body, allowing the infection to grow. Called non-structural protein 16, or nsp16, the enzyme is produced by the new coronavirus and acts as a “camouflage,” tricking human cells into thinking that the virus is “part of its own code and […]

The Ladders: Scientists just uncovered the sneaky way COVID-19 spreads so fast in cells

July 28, 2020

SARS-CoV-2, the coronavirus that causes COVID-19, has been labeled with a variety of different adjectives over the past few months. Deadly, awful, and evil, just to name a few. Now, according to a new study from the University of Texas Health Science Center San Antonio, another descriptor can be added to the coronavirus’ modus operandi: deceitful.